title: Regionally perfused taurine. Part I. Minimizes lactic acidosis and preserves CKMB and myocardial contractility after ischemia/reperfusion.
authors.affiliation: Kyoto University, Kyoto, Japan 606-8507.
authors.forename: Wnimunk
authors.initials: W
authors.lastname: Oriyanhan
authors.forename: Tadaomi A
authors.initials: TA
authors.lastname: Miyamoto
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Yamazaki
authors.forename: Senri
authors.initials: S
authors.lastname: Miwa
authors.forename: Kiyoaki
authors.initials: K
authors.lastname: Takaba
authors.forename: Tadashi
authors.initials: T
authors.lastname: Ikeda
authors.forename: Masashi
authors.initials: M
authors.lastname: Komeda
mesh_terms: D000818:Animals; D002314:Cardioplegic Solutions; D002316:Cardiotonic Agents / Q000378:metabolism; D052279:Creatine Kinase, MB Form / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D007035:Hypothermia; D019344:Lactic Acid / Q000097:blood*; D008297:Male; D009200:Myocardial Contraction / Q000502:physiology*; D017202:Myocardial Ischemia; D009206:Myocardium / Q000378:metabolism*; D018384:Oxidative Stress; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D013223:Statistics as Topic; D013654:Taurine / Q000008:administration & dosage / Q000378:metabolism*
chemical_list: D002314:Cardioplegic Solutions; D002316:Cardiotonic Agents; D013654:Taurine; D019344:Lactic Acid; D004247:DNA; D052279:Creatine Kinase, MB Form